91ÖÆƬ³§

Published on Market Research Reports® Inc. ()

Home > Global Small Molecule Injectable Market Research Report 2024

Global Small Molecule Injectable Market Research Report 2024

Publication ID: 
PB506246231
Publication Date: 
June 7, 2024
Pages: 
90
Publisher: 
MRRPB5
Countries: 
Global [1]
USD 2,900.00

Please choose the suitable license type from above. More details are given under tab "Report License Types" below.

Medical Devices [2]
Pharma & Healthcare [3]
Description: 

The global Small Molecule Injectable market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Small Molecule Injectable is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Small Molecule Injectable is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Small Molecule Injectable include Aurobindo Pharma Limited, Teva Pharmaceutical Industries Ltd., Merck & Co. Inc., AstraZeneca Plc, Pfizer Inc., Sun Pharmaceutical Industries Ltd., Novartis AG, Baxter International and Fresenius Kabi, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Small Molecule Injectable, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Small Molecule Injectable.
Report Scope
The Small Molecule Injectable market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Small Molecule Injectable market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Small Molecule Injectable manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Aurobindo Pharma Limited
Teva Pharmaceutical Industries Ltd.
Merck & Co. Inc.
AstraZeneca Plc
Pfizer Inc.
Sun Pharmaceutical Industries Ltd.
Novartis AG
Baxter International
Fresenius Kabi
Cipla Ltd
Mylan N.V.
Sanofi S.A
Dr. Reddy’s Laboratories Ltd
Segment by Type
Intravenous (IV)
Intramuscular (IM)
Subcutaneous (SC)
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Small Molecule Injectable manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Small Molecule Injectable in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents: 

1 Small Molecule Injectable Market Overview
1.1 Product Overview and Scope of Small Molecule Injectable
1.2 Small Molecule Injectable Segment by Type
1.2.1 Global Small Molecule Injectable Market Value Comparison by Type (2024-2030)
1.2.2 Intravenous (IV)
1.2.3 Intramuscular (IM)
1.2.4 Subcutaneous (SC)
1.3 Small Molecule Injectable Segment by Application
1.3.1 Global Small Molecule Injectable Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Small Molecule Injectable Market Size Estimates and Forecasts
1.4.1 Global Small Molecule Injectable Revenue 2019-2030
1.4.2 Global Small Molecule Injectable Sales 2019-2030
1.4.3 Global Small Molecule Injectable Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Small Molecule Injectable Market Competition by Manufacturers
2.1 Global Small Molecule Injectable Sales Market Share by Manufacturers (2019-2024)
2.2 Global Small Molecule Injectable Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Small Molecule Injectable Average Price by Manufacturers (2019-2024)
2.4 Global Small Molecule Injectable Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Small Molecule Injectable, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Small Molecule Injectable, Product Type & Application
2.7 Small Molecule Injectable Market Competitive Situation and Trends
2.7.1 Small Molecule Injectable Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Small Molecule Injectable Players Market Share by Revenue
2.7.3 Global Small Molecule Injectable Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Small Molecule Injectable Retrospective Market Scenario by Region
3.1 Global Small Molecule Injectable Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Small Molecule Injectable Global Small Molecule Injectable Sales by Region: 2019-2030
3.2.1 Global Small Molecule Injectable Sales by Region: 2019-2024
3.2.2 Global Small Molecule Injectable Sales by Region: 2025-2030
3.3 Global Small Molecule Injectable Global Small Molecule Injectable Revenue by Region: 2019-2030
3.3.1 Global Small Molecule Injectable Revenue by Region: 2019-2024
3.3.2 Global Small Molecule Injectable Revenue by Region: 2025-2030
3.4 North America Small Molecule Injectable Market Facts & Figures by Country
3.4.1 North America Small Molecule Injectable Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Small Molecule Injectable Sales by Country (2019-2030)
3.4.3 North America Small Molecule Injectable Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Small Molecule Injectable Market Facts & Figures by Country
3.5.1 Europe Small Molecule Injectable Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Small Molecule Injectable Sales by Country (2019-2030)
3.5.3 Europe Small Molecule Injectable Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Small Molecule Injectable Market Facts & Figures by Country
3.6.1 Asia Pacific Small Molecule Injectable Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Small Molecule Injectable Sales by Country (2019-2030)
3.6.3 Asia Pacific Small Molecule Injectable Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Small Molecule Injectable Market Facts & Figures by Country
3.7.1 Latin America Small Molecule Injectable Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Small Molecule Injectable Sales by Country (2019-2030)
3.7.3 Latin America Small Molecule Injectable Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Small Molecule Injectable Market Facts & Figures by Country
3.8.1 Middle East and Africa Small Molecule Injectable Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Small Molecule Injectable Sales by Country (2019-2030)
3.8.3 Middle East and Africa Small Molecule Injectable Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Small Molecule Injectable Sales by Type (2019-2030)
4.1.1 Global Small Molecule Injectable Sales by Type (2019-2024)
4.1.2 Global Small Molecule Injectable Sales by Type (2025-2030)
4.1.3 Global Small Molecule Injectable Sales Market Share by Type (2019-2030)
4.2 Global Small Molecule Injectable Revenue by Type (2019-2030)
4.2.1 Global Small Molecule Injectable Revenue by Type (2019-2024)
4.2.2 Global Small Molecule Injectable Revenue by Type (2025-2030)
4.2.3 Global Small Molecule Injectable Revenue Market Share by Type (2019-2030)
4.3 Global Small Molecule Injectable Price by Type (2019-2030)
5 Segment by Application
5.1 Global Small Molecule Injectable Sales by Application (2019-2030)
5.1.1 Global Small Molecule Injectable Sales by Application (2019-2024)
5.1.2 Global Small Molecule Injectable Sales by Application (2025-2030)
5.1.3 Global Small Molecule Injectable Sales Market Share by Application (2019-2030)
5.2 Global Small Molecule Injectable Revenue by Application (2019-2030)
5.2.1 Global Small Molecule Injectable Revenue by Application (2019-2024)
5.2.2 Global Small Molecule Injectable Revenue by Application (2025-2030)
5.2.3 Global Small Molecule Injectable Revenue Market Share by Application (2019-2030)
5.3 Global Small Molecule Injectable Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Aurobindo Pharma Limited
6.1.1 Aurobindo Pharma Limited Corporation Information
6.1.2 Aurobindo Pharma Limited Description and Business Overview
6.1.3 Aurobindo Pharma Limited Small Molecule Injectable Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Aurobindo Pharma Limited Small Molecule Injectable Product Portfolio
6.1.5 Aurobindo Pharma Limited Recent Developments/Updates
6.2 Teva Pharmaceutical Industries Ltd.
6.2.1 Teva Pharmaceutical Industries Ltd. Corporation Information
6.2.2 Teva Pharmaceutical Industries Ltd. Description and Business Overview
6.2.3 Teva Pharmaceutical Industries Ltd. Small Molecule Injectable Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Teva Pharmaceutical Industries Ltd. Small Molecule Injectable Product Portfolio
6.2.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
6.3 Merck & Co. Inc.
6.3.1 Merck & Co. Inc. Corporation Information
6.3.2 Merck & Co. Inc. Description and Business Overview
6.3.3 Merck & Co. Inc. Small Molecule Injectable Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck & Co. Inc. Small Molecule Injectable Product Portfolio
6.3.5 Merck & Co. Inc. Recent Developments/Updates
6.4 AstraZeneca Plc
6.4.1 AstraZeneca Plc Corporation Information
6.4.2 AstraZeneca Plc Description and Business Overview
6.4.3 AstraZeneca Plc Small Molecule Injectable Sales, Revenue and Gross Margin (2019-2024)
6.4.4 AstraZeneca Plc Small Molecule Injectable Product Portfolio
6.4.5 AstraZeneca Plc Recent Developments/Updates
6.5 Pfizer Inc.
6.5.1 Pfizer Inc. Corporation Information
6.5.2 Pfizer Inc. Description and Business Overview
6.5.3 Pfizer Inc. Small Molecule Injectable Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Pfizer Inc. Small Molecule Injectable Product Portfolio
6.5.5 Pfizer Inc. Recent Developments/Updates
6.6 Sun Pharmaceutical Industries Ltd.
6.6.1 Sun Pharmaceutical Industries Ltd. Corporation Information
6.6.2 Sun Pharmaceutical Industries Ltd. Description and Business Overview
6.6.3 Sun Pharmaceutical Industries Ltd. Small Molecule Injectable Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sun Pharmaceutical Industries Ltd. Small Molecule Injectable Product Portfolio
6.6.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
6.7 Novartis AG
6.6.1 Novartis AG Corporation Information
6.6.2 Novartis AG Description and Business Overview
6.6.3 Novartis AG Small Molecule Injectable Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novartis AG Small Molecule Injectable Product Portfolio
6.7.5 Novartis AG Recent Developments/Updates
6.8 Baxter International
6.8.1 Baxter International Corporation Information
6.8.2 Baxter International Description and Business Overview
6.8.3 Baxter International Small Molecule Injectable Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Baxter International Small Molecule Injectable Product Portfolio
6.8.5 Baxter International Recent Developments/Updates
6.9 Fresenius Kabi
6.9.1 Fresenius Kabi Corporation Information
6.9.2 Fresenius Kabi Description and Business Overview
6.9.3 Fresenius Kabi Small Molecule Injectable Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Fresenius Kabi Small Molecule Injectable Product Portfolio
6.9.5 Fresenius Kabi Recent Developments/Updates
6.10 Cipla Ltd
6.10.1 Cipla Ltd Corporation Information
6.10.2 Cipla Ltd Description and Business Overview
6.10.3 Cipla Ltd Small Molecule Injectable Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Cipla Ltd Small Molecule Injectable Product Portfolio
6.10.5 Cipla Ltd Recent Developments/Updates
6.11 Mylan N.V.
6.11.1 Mylan N.V. Corporation Information
6.11.2 Mylan N.V. Small Molecule Injectable Description and Business Overview
6.11.3 Mylan N.V. Small Molecule Injectable Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Mylan N.V. Small Molecule Injectable Product Portfolio
6.11.5 Mylan N.V. Recent Developments/Updates
6.12 Sanofi S.A
6.12.1 Sanofi S.A Corporation Information
6.12.2 Sanofi S.A Small Molecule Injectable Description and Business Overview
6.12.3 Sanofi S.A Small Molecule Injectable Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Sanofi S.A Small Molecule Injectable Product Portfolio
6.12.5 Sanofi S.A Recent Developments/Updates
6.13 Dr. Reddy’s Laboratories Ltd
6.13.1 Dr. Reddy’s Laboratories Ltd Corporation Information
6.13.2 Dr. Reddy’s Laboratories Ltd Small Molecule Injectable Description and Business Overview
6.13.3 Dr. Reddy’s Laboratories Ltd Small Molecule Injectable Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Dr. Reddy’s Laboratories Ltd Small Molecule Injectable Product Portfolio
6.13.5 Dr. Reddy’s Laboratories Ltd Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Small Molecule Injectable Industry Chain Analysis
7.2 Small Molecule Injectable Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Small Molecule Injectable Production Mode & Process
7.4 Small Molecule Injectable Sales and Marketing
7.4.1 Small Molecule Injectable Sales Channels
7.4.2 Small Molecule Injectable Distributors
7.5 Small Molecule Injectable Customers
8 Small Molecule Injectable Market Dynamics
8.1 Small Molecule Injectable Industry Trends
8.2 Small Molecule Injectable Market Drivers
8.3 Small Molecule Injectable Market Challenges
8.4 Small Molecule Injectable Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned: 

Aurobindo Pharma Limited
Teva Pharmaceutical Industries Ltd.
Merck & Co. Inc.
AstraZeneca Plc
Pfizer Inc.
Sun Pharmaceutical Industries Ltd.
Novartis AG
Baxter International
Fresenius Kabi
Cipla Ltd
Mylan N.V.
Sanofi S.A
Dr. Reddy’s Laboratories Ltd

License Types: 

Single User License (PDF)

  • This license allows for use of a publication by one person.
  • This person may print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

Ìý

Site License (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

Ìý

Global License (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Source URL:/mrrpb5/global-small-molecule-injectable-market-research-report-2024

Links
[1] /countries/global[2] /medical-devices[3] /pharma-healthcare